🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07785960
Enrolling by invitation Not applicable

Recovery and Early Sleep Tracking Using the SuperPatch REM Patch

NCT07785960 · tracked via the Priya Life Science UK tracker
Sponsor
SuperPatch Limited LLC
Phase
Not applicable
Started
2026-05-15
Last updated
2026-08-25

Condition(s) studied

Shift Work Sleep DisorderShift Work Type Circadian Rhythm Sleep DisorderShift Work Sleep Disorders

Investigational drug(s) / intervention(s)

SuperPatch REM PatchSham REM Patch

SuperPatch REM Patch: A drug-free, non-invasive vibrotactile (haptic) patch applied to the skin immediately prior to post-night-shift sleep and removed upon waking, intended to support recovery signals around sleep including sleep staging and autonomic metrics. Applied across 3-4 post-night-shift sleep episodes.

Sham REM Patch: A visually identical sham patch without vibrotactile technology, applied using the same timing, wear duration, and procedure as the active patch.

Study summary

A Phase 1 Feasibility Study of the SuperPatch REM Patch for Post-Night-Shift Sleep Recovery in NHS Doctors

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Adult doctors (≥18 years) working regular night shifts * Able to provide informed consent and comply with remote study procedures * Willing to wear a sleep-tracking wearable during the study period * Willing to apply an adhesive study patch during designated post-shift sleep episodes Exclusion Criteria: * Known allergy/sensitivity to adhesives or significant dermatologic condition affecting patch placement * Concurrent use of another device adhered to the body at the same site that could interfere with patch placement * Any condition judged by investigators to make participation unsafe or data uninterpretable (e.g., acute illness impacting sleep)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Vichag Ltd Birmingham West Midlands
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07785960 on ClinicalTrials.gov ↗ ← All trials in the UK